Abstract
The interface between psychotropic medication, neurobiology, and mental illnesses should be more adequately recognized by clinical and other social workers. This article argues for this claim by examining its consistency with current policies of the National Institute of Mental Health and by discussing understandings about the relationship between neurobiology and mental illness and medication.
Additional information
Notes on contributors
Rosemary L. Farmer
Rosemary L. Farmer, PhD, LCSW, is an associate professor at the School of Social Work, Virginia Commonwealth University, where she teaches clinical social work practice, psychopathology, and social work practice and the neurosciences.